Literature DB >> 33802254

Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis.

Mahdi Al-Jeabory1, Lukasz Szarpak2, Kecskes Attila3, Michael Simpson4, Adam Smereka5, Aleksandra Gasecka6,7, Wojciech Wieczorek8, Michal Pruc1, Maciej Koselak9, Wladyslaw Gawel10, Igor Checinski11, Milosz J Jaguszewski12, Krzysztof J Filipiak6.   

Abstract

In trauma patients, bleeding can lead to coagulopathy, hemorrhagic shock, and multiorgan failure, and therefore is of fundamental significance in regard to early morbidity. We conducted a meta-analysis to evaluate the efficacy and safety of tranexamic acid (TXA) in civil and military settings and its impact on in-hospital mortality (survival to hospital discharge or 30-day survival), intensive care unit and hospital length of stay, incidence of adverse events (myocardial infarct and neurological complications), and volume of blood product transfusion. The systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic review of the literature using PubMed, Scopus, EMBASE, Web of Science, and the Cochrane Central Register and Controlled Trials (CENTRAL) database was conducted from inception to 10 January 2021. In-hospital mortality was reported in 14 studies and was 15.5% for the TXA group as compared with 16.4% for the non-TXA group (OR = 0.81, 95% CI 0.62-1.06, I2 = 83%, p = 0.12). In a civilian TXA application, in-hospital mortality in the TXA and non-TXA groups amounted to 15.0% and 17.1%, respectively (OR = 0.69, 95% CI 0.51-0.93, p = 0.02, I2 = 78%). A subgroup analysis of the randomized control trial (RCT) studies showed a statistically significant reduction in in-hospital mortality in the TXA group (14.3%) as compared with the non-TXA group (15.7%, OR = 0.89, 95% CI 0.83-0.96, p = 0.003, I2 = 0%). To summarize, TXA used in civilian application reduces in-hospital mortality. Application of TXA is beneficial for severely injured patients who undergoing shock and require massive blood transfusions. Patients who undergo treatment with TXA should be monitored for clinical signs of thromboembolism, since TXA is a standalone risk factor of a thromboembolic event and the D-dimers in traumatic patients are almost always elevated.

Entities:  

Keywords:  bleeding; emergency medicine; meta-analysis; mortality; systematic review; tranexamic acid; trauma

Year:  2021        PMID: 33802254      PMCID: PMC7958951          DOI: 10.3390/jcm10051030

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  43 in total

1.  Tranexamic acid in major trauma: implementation and evaluation across South West England.

Authors:  Priyamvada Paudyal; Jason Smith; Maria Robinson; Adrian South; Ian Higginson; Adam Reuben; Julian Shaffee; Sarah Black; Stuart Logan
Journal:  Eur J Emerg Med       Date:  2017-02       Impact factor: 2.799

2.  A double blind study of the effect of tranexamic acid in essential menorrhagia.

Authors:  J Vermylen; M L Verhaegen-Declercq; F Fierens; M Verstraete
Journal:  Bull Soc R Belge Gynecol Obstet       Date:  1968

3.  Tranexamic acid in the prehospital setting: Israel Defense Forces' initial experience.

Authors:  Ari M Lipsky; Amir Abramovich; Roy Nadler; Uri Feinstein; Gadi Shaked; Yitshak Kreiss; Elon Glassberg
Journal:  Injury       Date:  2013-09-07       Impact factor: 2.586

4.  Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations.

Authors:  D Frith; J C Goslings; C Gaarder; M Maegele; M J Cohen; S Allard; P I Johansson; S Stanworth; C Thiemermann; K Brohi
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

Review 5.  Advances in the understanding of trauma-induced coagulopathy.

Authors:  Ronald Chang; Jessica C Cardenas; Charles E Wade; John B Holcomb
Journal:  Blood       Date:  2016-07-05       Impact factor: 22.113

6.  Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical Trial.

Authors:  Francis X Guyette; Joshua B Brown; Mazen S Zenati; Barbara J Early-Young; Peter W Adams; Brian J Eastridge; Raminder Nirula; Gary A Vercruysse; Terence O'Keeffe; Bellal Joseph; Louis H Alarcon; Clifton W Callaway; Brian S Zuckerbraun; Matthew D Neal; Raquel M Forsythe; Matthew R Rosengart; Timothy R Billiar; Donald M Yealy; Andrew B Peitzman; Jason L Sperry
Journal:  JAMA Surg       Date:  2020-10-05       Impact factor: 14.766

7.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

8.  The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG): a meta-analysis of 28 randomized controlled trials.

Authors:  Yanting Zhang; Yun Bai; Minmin Chen; Youfa Zhou; Xin Yu; Haiyan Zhou; Gang Chen
Journal:  BMC Anesthesiol       Date:  2019-06-14       Impact factor: 2.217

9.  The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study.

Authors:  Peng Xue; Junsong Yang; Xiaozhou Xu; Tuanjiang Liu; Yansheng Huang; Feng Qiao; Xiaoqiang Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

10.  Tranexamic acid reduces heme cytotoxicity via the TLR4/TNF axis and ameliorates functional recovery after spinal cord injury.

Authors:  Shingo Yoshizaki; Ken Kijima; Masamitsu Hara; Takeyuki Saito; Tetsuya Tamaru; Masatake Tanaka; Dai-Jiro Konno; Yasuharu Nakashima; Seiji Okada
Journal:  J Neuroinflammation       Date:  2019-07-29       Impact factor: 8.322

View more
  2 in total

1.  Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury: A Systematic Review and Meta-analysis.

Authors:  Vivien Karl; Sophie Thorn; Tim Mathes; Simone Hess; Marc Maegele
Journal:  JAMA Netw Open       Date:  2022-03-01

2.  Efficacy and safety of the second in-hospital dose of tranexamic acid after receiving the prehospital dose: double-blind randomized controlled clinical trial in a level 1 trauma center.

Authors:  Ayman El-Menyar; Khalid Ahmed; Suhail Hakim; Ahad Kanbar; Saji Mathradikkal; Tariq Siddiqui; Hisham Jogol; Basil Younis; Ibrahim Taha; Ismail Mahmood; Ahmed Ajaj; Sajid Atique; Abubaker Alaieb; Ahmed Abdel-Aziz Bahey; Mohammad Asim; Guillaume Alinier; Nicholas R Castle; Ahammed Mekkodathil; Sandro Rizoli; Hassan Al-Thani
Journal:  Eur J Trauma Emerg Surg       Date:  2021-12-15       Impact factor: 2.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.